Fetal samples were obtained from voluntarily or spontaneously terminated pregnancies, with the parents' informed consent and according to the French Ethical Committee's regulations. Embryos were staged using Carnegie classification from stage 10 to stage 20 (Larsen, 1993) . The gestational ages of fetuses varied from 6 to 35 weeks. The age of each subject was established by first trimester ultrasound crown-rump length measurement and confirmed at autopsy by the estimation of organ and skeletal maturation. FL samples from gestation weeks 6 to 10 corresponded to discarded tissues following voluntarily terminated pregnancies. Ribs, femura, thymuses, spleens, and FLs harvested beyond gestation week 10 were sterilely excised within 48 hrs after recovery and processed in RPMI 1640 medium (GIBCO BRL Life Technologies, Cergy Pontoise, France). BM cells obtained before gestation week 15, which corresponds to BM development stages III-IV according to Charbord's classification (Charbord et al., 1996) , were recovered by gentle flushing flat bones in RPMI 1640 medium, washed and filtered through a cell strainer (70 µm; Becton Dickinson, Mountain View, CA). For later samples (BM development stage V), the long bones were carefully dissected and cut into small fragments before BM cells were obtained by incubation in RPMI 1640, 10 U/ml RNase-free DNase I (Roche Diagnostics, Meylan, France). Thymus, spleen and liver samples were incubated for 30 min at 37°C in RPMI 1640, 100 U/ml type VII collagenase (Sigma-Aldrich, St Quentin Fallavier, France), before mechanical disruption with microsurgery instruments and passage through the cell strainer. Post-natal thymuses were obtained from 5-day-to 4-year-old children undergoing corrective cardiac surgery (Service de Chirurgie Cardiaque Pédiatrique, hôpital Necker, Paris, France). Following collagenase treatment and cell strainer filtration, MNCs were separated by Pancoll centrifugation (Dutscher, Brumath, France). Post-natal BM from 1-to 50-year-old healthy BM graft donors
Isolation and Immunolabeling of CD34
+ Cells CD34 + HPCs were separated from other cells with the midiMACS ® system (Miltenyi Biotech France, Paris, France) with a purity ≥85%. For FACSsorting (FACSvantage®; Becton Dickinson), CD34 + cells were labeled with CD34-phycoerythrocyanin 5 (PECy5) or CD34-allophycocyanin (APC) (clone 581), CD7-fluorescein isothiocyanate (FITC) (clone 8H8.1) (all from Beckman Coulter, Villepinte, France), CD45RA-phycoerythrin (PE) (clone HI100; BD Pharmingen, Le Pont de Claix, France), or CD10-PECy5 (clone A1B1; Beckman Coulter) mAbs, and processed as described (purity >90%) (Haddad et al., 2004) . For phenotyping, CD34 + cells were incubated for 30 min at 4°C with the corresponding mAbs (1:100 final unless specified) in PBS, 2% fetal calf serum (FCS), washed and analyzed with a FACscalibur ® (Becton Dickinson). Cells were labeled with PE-, PECy5-, or APC-conjugated CD34 mAb clone 581, and the following mAbs: CD1a-APC (clone HI149; BD Pharmingen, Le Pont de Claix, France), CD2-PE (clone 39C1.5; Beckman Coulter), CD3-PE (clone HIT3a; BD Pharmingen, Le Pont de Claix, France), CD5-FITC (clone UCHT2; BD Pharmingen), CD5-PE (clone Bl1a; Beckman Coulter), CD45RA-PE, CD45RA-PECy5 (clone HI100; BD Pharmingen), CD7-FITC (clone 8H8.1; Beckman Coulter), CD19-FITC (clone HIB19; BD Pharmingen), CD10-PECy5 (clone A1B1; Beckman Coulter) , CD33-PE (clone WM53), CD38-APC (clone HIT2; BD Pharmingen), CD97-PE (clone VIM 3b, BD Pharmingen), CD127-PE (clone R34.34; Beckman Coulter), CXCR4-PE (clone 12G5, BD Pharmingen), CCR5-PE (clone 2D7, BD Pharmingen), CCR7-PE (clone 3D12, BD Pharmingen), CCR9 (clone 112509, R&D Systems, MN). Isotype-matched FITC-, PE-and APC-conjugated irrelevant or goat anti-mouse antibodies were from BD Pharmingen and Beckman Coulter; non-conjugated mouse isotype controls were from Beckman Coulter and Caltag (San Francisco, CA).
Clonogenic Assays
The erythroid and granulo-macrophagic potential of each CD34 + HPC subset was assessed by seeding 500 cells in 35 mm duplicate dishes (Dutscher), in 1.1 ml complete Methocult TM GF+ H4435 medium (Stem Cell Technologies, Meylan, France), supplemented with interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor (G-CSF), stem cell factor (SCF), granulocyte macrophage (GM)-CSF and erythropoietin (EPO). Dishes were incubated at 37°C in humidified 5% CO2. Erythroid burst-forming units (BFU-E), granulocyte (CFU-G/GM) and macrophage (CFU-M) colony-forming units were counted under an inverted microscope on culture day 14.
NK Cells, B, and DC Differentiation Assays
Cultures under conditions to generate NK cells or BLs from sorted CD34+ HPC populations were performed essentially as described (Haddad et al., 2004) . Briefly, CD34 + cells were seeded onto murine MS5 stromal cells with either SCF, Flt-3 ligand (Flt-3L), IL-2, IL-7 and IL-15 (NK condition) or SCF, thrombopoietin (TPO) and IL-7 (B condition). Cultures were conducted for 2 weeks in 48-well plates (Dutscher) before cells were collected and labeled with CD56-PE (clone B159) and CD19-FITC (clone HIB19) (both from BD Pharmingen) or CD19-PE (clone J4.119; Coulter Immunotech) mAbs to detect NK cells and BLs, respectively. Cultures to generate DCs, with SCF, FL, GM-CSF, and TNF-α (Genzyme, Cambridge, MA), were performed as described (Canque et al., 2000) . After 8-day culture, non-adherent cells were labeled with CD1a-FITC (clone HL149, Pharmingen) and PE-conjugated HLA-DR (clone L243, Beckman Coulter) and CD207 (clone DCGM4, Immunotech) mAbs to detect DCs and/or Langerhans cells.
TL Differentiation Assays
FTOCs were essentially performed as reported (Haddad et al., 2004; Robin et al., 1999) . Briefly, thymus lobes were collected from day 14 -15 NOD/SCID mice embryos. Hanging drops were cultured for 48 hrs in Terasaki plates (Polylabo, Strasbourg, France) with SCF, IL-2 and IL-7, and 0.5 to 3 x 10 4 cells/lobe (2 to 5 lobes/condition). Lobes were then transferred onto floating nucleopore filters (Millipore SA, France) and cultured for 4 weeks. Human cells were labeled with CD45-FITC or -APC, CD4-PECy5 or -PE, CD8-APC or -FITC, and TCRαβ-PE (all from Beckman Coulter) before FACS analysis.
Cocultures with OP9-DL1 stromal cells were conducted in α-MEM (GIBCO BRL Life Technologies), 20% FCS (Hyclone Perbio, Erenbodegem-Aalst, Belgium) in the presence of IL-7 and Flt-3L (R&D Systems), as described (De Smedt et al., 2004; La Motte-Mohs et al., 2005) . OP9 murine stromal cells expressing human Notch ligand Delta-1 (OP9-DL1) were produced by retroviral-mediated gene transfer with a bicistronic Delta-1-IRES-GFP construct and selected based on GFP expression. By culture weeks 2, 3, 4 and 5, the cells were double-labeled with APC- ( 
Gene Expression Analysis
Total RNAs were extracted using the RNeasy Mini Kit (Qiagen, Hildren, Germany). RNA quality control and quantification were monitored by spectrophotometry and capillary electrophoresis using the RNA 6000 Pico LabChip® Kit and the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). RNAs (starting amounts: 15 ng) were reverse transcribed using random hexamers with Superscript II reverse transcriptase (Invitrogen life technologies, Cergy Pontoise, France) before being subjected to 12 cycles of preamplification with the BD Super SMART TM PCR cDNA synthesis Kit (BD Biosciences Clontech, Palo Alto, CA). Doublestranded PCR-amplified cDNAs were then purified by using the Wizard DNA clean-up system (Promega France, Charbonnieres, France) before being subjected to phenol/chloroform extraction and quantified by spectrophotometry. Detection of lineage-affiliated gene transcipts was achieved by subjecting 50 ng cDNA to 40-(MPO, E2A, LEF1, RAG1, PTCRA, TRGV2, TRGV9) or 45-cycle (RAG2) amplification with the appropriate primer pairs (Table S1 ). PCR amplification for each population was repeated with two independently prepared cDNA samples. PCR products were subjected to electrophoresis on a 2% agarose gel, followed by ethidium bromide staining. Fractions were normalized relative to GAPDH expression levels.
Thymus Histology
Embryos or fetal samples were fixed in 4% paraformaldehyde and embedded in paraffin. Semi-thin sections (4 µm) were dewaxed with xylene, and bathed consecutively in absolute ethanol, 75% ethanol, 35% ethanol, and H 2 O. Slides were then incubated for 20 min at 95-98°C in 10 mM sodium citrate, pH 6.0, and cooled for 20 min at room temperature. Paraffin sections were washed three times in phosphate-buffered saline (PBS), and blocked for 30 min in PBS, 3% BSA, 0.1% Tween-20, before incubation with primary mAbs for 90 min at 37°C. Slides were washed three times in PBS, 0.1% Tween-20, before adding secondary reagents for 1 hr at room temperature. Labeling was developed by incubation with tertiary antibodies for 1 hr at room temperature. Negative controls were tissue sections incubated without primary mAbs and concentration-matched secondary and tertiary antibodies. Slides were counterstained with 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) and mounted in XAM neutral medium (BDH, Poole, UK). Primary mAbs were mouse anti-human von Willebrand factor (clone F8/86, dilution 1:50), CD1a (clone 010, dilution 1:50), or cytokeratin (clone MNF116, dilution 1:100) (all from Dako, France); goat anti-human CD34 (clone C-18, dilution 1:400) (Santa Cruz, USA). Labeling with mouse primary mAbs was developed by biotinylated rabbit anti-mouse IgG (dilution 1:400) followed by Cy-3-conjugated Streptavidin (1:150) (all from Sigma). Labeling with goat anti-human CD34 was developed by sequential incubation with chicken anti-goat IgG and goat anti-chicken IgG, both conjugated with Alexa-488 (dilution 1:100) (Molecular Probes). Sections were analyzed by a Zeiss LSM 510 META confocal laser microscope (Zeiss, Iena, Germany). Images were acquired as indicated at 20X, 40X or 63X magnifications. 2D and 3D deconvolutions were performed with the AutoDeblur © v93 software (AutoQuant Imaging Inc, NY), and 3D reconstructions were performed with the Amira 3.1 software (Visual Concept GmbH, TGS Inc, Germany). -HPC populations were sorted from UCB CD34 + cells before they were independently labeled in PBS with CFSE according to the manufacturer's instructions (Molecular Probes). CFSE-labeled cell populations were then resuspended in IMDM, 10% human AB serum. Hanging drops were prepared in Terasaki plates by adding 25 µl of cell suspension to each lobe (5 x 10 3 cells/lobe) with or without SCF, IL-2 and IL-7. Inverted plates were subsequently incubated for 48 hrs before lobes were washed by gentle dipping in PBS, transferred onto floating nucleopore filters (Millipore SA, France) and immediately processed for microscopy. Specimens were gently layered on glass coverslips that were subsequently inverted onto single concave microscope slides containing 50 µl RPMI 1640 medium without phenol red and kept at 37°C throughout the experiment. One-and two-photon excitation confocal observations of samples were carried out with a Leica TCS SP2 AOBS multiphoton CLSM (Leica Wetzlar, Germany) equipped with an accordable titanium:sapphire Tsunami Spectra Physics laser (Spectra Physics, Newport Corporation, Mountain View, CA). Images at 0.2-1.46 µm (x,y) pixel sizes were obtained for each case in 512 x 512 arrays depending on the required sizes of the whole thymus lobes and selected parts at 20X magnification (HCPL APO CS2, NA 0.7, oil). Two-photon excitation by the titanium:sapphire laser was obtained at 800 nm. This infra-red excitation line is equivalent to the blue excitation line which has been used in the one-photon CLSM mode (488 nm). In the case of one-photon excitation CLSM experiments the pinhole size was 120 µm. The acquisitions resulted in images in the 500-580 nm emission range. In all cases, Nomarsky imaging was performed as a rapid means of accessing thymus structure. Three-dimensional one-and two-photon acquisitions and 3D reconstructions were performed as above. 
Thymus Colonization Assays

CD10
+ cells still account for 9 ± 2% of CD34 hi/int FSC hi HPCs (median: 9%; range: 6 to 15 %, n = 9) between 1 and 10 years of age, and for 3 ± 1% (median: 3%; range 1 to 11%, n = 17) thereafter. These results are consistent with a previous report (Rossi et al., 2003) . (B) Gestation weeks 13 and 20 BM and spleen MNCs were analyzed as above.
hi CD7 + HPCs are detected among splenocytes as early as gestation week 13. Given that the fetal spleen lacks hematopoietic activity, it may be assumed that the presence of the cells in the spleen indicates that they circulate in the fetal blood. Although no direct link can be established between the two, that only rare CD34 hi CD45RA hi CD7 + HPCs are still detected in the postnatal BM supports the idea of progressive decrease of the thymic influx beyond 5 months postnatal. These data are consistent with a report that atrophy of thymus epithelial spaces (TES) becomes detectable as early as one year of age and associates with progressive decrease of signal joint (sj) TREC numbers per unit of whole thymus tissue weight (Sempowski et al., 2000) . Cortico-medullar partitioning is first detected by gestation week 13, which confirms previous reports (Haar, 1974; Lobach et al., 1985) . CD34 labeling to detect vascular structures discloses a bifocal repartition of the blood vessels at the periphery of the thymus lobules in the subcapsular zone and interlobular septa, as well as in the inner cortex up to the cortico-medullar junction (dashed line). 
CD7
+ HPCs do not express detectable RAG1 and RAG2 transcripts, which is consistent with the finding that, although endowed with T cell differentiation potential, this population retains some capacity to generate B cells, NK cells and dendritic cells as well as granulo-monocytic cells.
Phenotyping of CD34 hi
CD1a
-fetal thymocytes failed to provide evidence that hematopoietic stem cells participate to thymus colonization (Dik et al., 2005; Spits, 2002) . Although the most immature "large"
-thymocytes (referred to as CD1a -CD4 -CD8 -triple-negative-1 [TN1]) are CD38 lo/-, they coexpress high CD45RA and CD7 levels (Fig. 3B , and data not shown). That this population essentially lacks a granulo-monocytic potential when cultured in semi-solid assays, and retains only a minor B differentiation potential, supports the assumption that specification toward the T lineage is initiated as soon as the prethymocytes gain access to the thymus parenchyma. Also consistent with the idea that the TN1 thymocytes have already entered the T differentiation pathway, we found that they localize in the vicinity of perivascular sheaths where they closely interact with thymus epithelial cell projections.
Acquisition of CD127/IL-7R expression at the subsequent "large" TN2 stage correlates with definitive loss of B cell potential. Finally, that TN2 thymocytes still generate NK cells and dendritic cells indicates that definitive commitment toward the T lineage occurs at the transition between the TN2 and double-negative (DN) CD34 lo CD1a + CD4 lo stages, and confirms a recent murine report (Benz and Bleul, 2005 + transition and coincides with the early onset of the TCRβ locus rearrangement (Dik et al., 2005) , as well as with the observation than only rare DβJβ TRECs are detected in most immature CD34 int CD1a -post-natal thymocytes (Dion et al., 2004) . TCRβ selection is initiated in immature single-positive CD4 lo thymocytes (ISP). 
